Sanofi-Aventis and Nichi-Iko lay out plans for new Japanese generics venture
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis chose Nichi-Iko as its partner for entering the generics sector in Japan as it was attracted by the company's strong business growth, market presence, entrepreneurial spirit and know-how.